PDS Biotech Announces Conference Call and Webcast for Second Quarter 2025 Financial Results

PRINCETON, N.J., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that the Company will host a conference call to report financial results for the quarter ended June 30, 2025 and provide a clinical programs update on Wednesday, August 13, 2025 at 8:00 am Eastern Time.

Read more at globenewswire.com